Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia
NCT00003746
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Leukemia
Interventions
DRUG:
2-chlorodeoxyadenosine (CDA) daily
DRUG:
2-chlorodeoxyadenosine weekly
Sponsor
Swiss Cancer Institute